Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

News: Brain Tumors

Cancer Survivors’ Day Highlights

Tuesday, June 21st, 2011

More than 350 cancer survivors, caregivers, advocates and health professionals gathered at the Vanderbilt Student Life Center last Saturday (June 18, 2011) to learn, connect and celebrate. Cancer GPS: Navigating Your Journey included remarks from keynote speaker Linda Armstrong Kelly (author and mother of champion cyclist and survivor Lance Armstrong), music and stories from survivor, […]

Weaver Honored by Neuro Association

Friday, June 10th, 2011

Kyle Weaver, M.D., assistant professor of Neurological Surgery, has received the Preuss Award from the Joint Section on Tumors of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS). The Preuss Award is given to a young scientist investigating brain tumors who submitted the best basic science research paper. First […]

How Is Brain Cancer Surgery Like Real Estate?

Monday, May 16th, 2011

Back in April, one of Vanderbilt-Ingram Cancer Center’s faculty members, Dr. Reid Thompson, was a featured presenter at TEDx Nashville. The event included artists, actors, musicians, a rocket scientist, a dancer, and others, all speaking on the topic “A Sense of Wonder.” Here’s is Dr. Thompson’s TEDx Talk, in which he describes the wonder that […]

Dozens at VICC Listed Among Best Doctors

Thursday, May 5th, 2011

Two popular surveys that recognize physician expertise have again included hundreds of doctors from Vanderbilt University Medical Center, including 40 involved in the care for cancer patients and their caregivers. America’s Top Doctors listed 59 Vanderbilt physicians, while Best Doctors in America included 227 Vanderbilt faculty members. One or both lists included 40 members of […]

Thompson Details Brain’s Wonders at TEDxNashville

Friday, April 15th, 2011

The do-it-yourself rocket scientist from Alabama was a tough act to follow at Saturday’s TEDxNashville, but Reid Thompson, M.D., pulled it off, wowing the packed performance hall with the “sense of wonder” that he finds every day in the operating room. “I remember vividly the first time I touched a human brain,” began Thompson, William […]

Have You Checked Out Cancer Connect Yet?

Thursday, February 10th, 2011

Vanderbilt-Ingram Cancer Center has joined with the national CancerConnect.com initiative to launch a new online support community for people impacted by cancer, including patients, family members, friends and advocates. Participants don’t have to be a Vanderbilt-Ingram patient or family member to join the online community. There they can share stories, ask questions and learn from […]

Share Your Stories, Art

Wednesday, January 5th, 2011

Tabula Rasa, the School of Medicine’s journal of medical humanities, is now accepting submissions for its 2010-2011 issue. The theme of this year’s journal is “Transformation: How Illness and Healing Change Us.” All submissions that meet the criteria (see below) will be featured on the Tabula Rasa website, and many of the selected submissions will […]

Call Center Operations Restored

Tuesday, January 4th, 2011

Update as of Thursday, Jan. 6: Call Center staff have been relocated to temporary locations, with phones and computers, so our service has been restored. Thanks to everyone for their patience while we addressed this unexpected situation. Kudos to our team for their dedication to finding a way to get back on line for our […]

New Online Community for Survivors

Friday, December 31st, 2010

Editor’s note: Cynthia Floyd Manley, Vanderbilt-Ingram Cancer Center’s associate director for communications, will appear on Lifetime Television’s The Balancing Act on Monday, Jan. 3, to discuss social networking for cancer survivors and caregivers. Vanderbilt-Ingram Cancer Center has joined with the national CancerConnect.com initiative to launch a new online community for people impacted by cancer. As […]

Clinical Trials in Era of Targeted Therapies

Friday, December 17th, 2010

Cousins with melanoma caused by the same genetic mutation enroll in a randomized clinical trial of a promising experimental drug that targets the mutation. Randomly assigned to different groups, one young man gets the new drug, experiences dramatic shrinkage of his tumors and is alive nine months later, while his cousin receives current therapy — […]

Next Page »« Previous Page